A BILL 
To provide for a vaccine safety public awareness campaign. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘COVID–19 Vaccine 
4
Awareness Support Act of 2020’’. 
5
SEC. 2. VACCINE SAFETY PUBLIC AWARENESS CAMPAIGN. 
6
(a) IN GENERAL.—The Secretary of Health and 
7
Human Services (referred to in this section as the ‘‘Sec-
8
retary’’), acting through the Director of the Centers for 
9
Disease Control and Prevention and in coordination with 
10
the Office of Minority Health and the Federal Office of 
11
00:08 Dec 29, 2020
H8966
2 
•HR 8966 IH
Rural Health Policy of the Department of Health and 
1
Human Services, and, as appropriate, with the relevant 
2
Offices of Minority Health of the Department of Health 
3
and Human Services, the National Institute on Minority 
4
Health and Health Disparities, and the Indian Health 
5
Service, shall establish grant funding opportunities for eli-
6
gible entities to carry out a national, evidence-based cam-
7
paign to disseminate COVID–19 vaccination information. 
8
(b) ELIGIBLE ENTITIES.—To be eligible to receive a 
9
grant under this section, an entity shall— 
10
(1) be a State, local, Tribal, or territorial health 
11
department, an urban Indian organization (as de-
12
fined in section 4 of the Indian Health Care Im-
13
provement Act (25 U.S.C. 1603)), a nonprofit com-
14
munity-based organization, or a nonprofit faith- 
15
based organization; and 
16
(2) agree to— 
17
(A) work in consultation with relevant 
18
State and local health officials, health care pro-
19
viders, health care facilities, and other appro-
20
priate stakeholders to carry the campaign under 
21
this section; and 
22
(B) submit to the Secretary, within 30 
23
days of receipt of a grant, a proposed plan for 
24
use of the grant funds. 
25
00:08 Dec 29, 2020
H8966
3 
•HR 8966 IH
(c) USE OF FUNDS.— 
1
(1) IN GENERAL.—Entities receiving a grant 
2
under this section shall use such grant funds to— 
3
(A) increase awareness and knowledge of 
4
the safety and effectiveness of vaccines ap-
5
proved or authorized by the Food and Drug Ad-
6
ministration for the prevention and control of 
7
COVID–19 and the benefit of receiving a 
8
COVID–19 vaccine; 
9
(B) provide information on where the vac-
10
cine can be obtained; and 
11
(C) create multilingual and culturally ap-
12
propriate messaging to disseminate scientific 
13
and evidence-based information related to vac-
14
cines. 
15
(2) DETAILS OF CAMPAIGNS.—Information dis-
16
seminated by an entity receiving a grant under this 
17
section shall— 
18
(A) be based on available scientific evi-
19
dence; 
20
(B) increase awareness and knowledge of 
21
COVID–19, including countering stigma associ-
22
ated with COVID–19; 
23
(C) improve information on the availability 
24
of COVID–19 vaccines, including countering 
25
00:08 Dec 29, 2020
H8966
4 
•HR 8966 IH
misinformation and disinformation with evi-
1
dence-based scientific rebuttals; and 
2
(D) improve awareness and knowledge of 
3
coverage of COVID–19 vaccines. 
4
(d) PRIORITIZATION.—In awarding grants under this 
5
section, the Secretary shall give priority to eligible entities 
6
in either urban or rural communities (or a combination 
7
of urban and rural communities) that serve vulnerable 
8
populations, including communities of color, which may in-
9
clude low-income, uninsured, and medically underserved 
10
individuals or populations with historically low rates of re-
11
ceiving vaccines. 
12
(e) TIMING.—The Secretary shall awards the grants 
13
under this section not later than 30 days after the earlier 
14
of— 
15
(1) the date on which the Food and Drug Ad-
16
ministration licenses a COVID–19 vaccine under 
17
section 351 of the Public Health Service Act (42 
18
U.S.C. 262); or 
19
(2) the date on which a manufacturer begins to 
20
distribute a COVID–19 vaccine to public or private 
21
entities pursuant to an emergency use authorization 
22
under section 564 of the Federal Food, Drug, and 
23
Cosmetic Act (21 U.S.C. 360bbb–3). 
24
(f) EVALUATION.—The Secretary shall— 
25
00:08 Dec 29, 2020
H8966
5 
•HR 8966 IH
(1) conduct qualitative assessments regarding 
1
the campaign under this section; and 
2
(2) not later than one year after the date of en-
3
actment of this Act, prepare and submit to the Com-
4
mittee on Appropriations and the Committee on 
5
Health, Education, Labor, and Pensions of the Sen-
6
ate and the Committee on Appropriations and the 
7
Committee on Energy and Commerce of the House 
8
of Representatives an evaluation of the campaign 
9
under this section. 
10
(g) AUTHORIZATION OF APPROPRIATIONS.—There is 
11
authorized to be appropriated to carry out this section 
12
such sums as may be necessary for fiscal year 2021. 
13
Æ 
00:08 Dec 29, 2020
H8966
